part_subject: "PUBLIC HEARING BEFORE A PUBLIC ADVISORY COMMITTEE"
subpart_code: "I"
subpart_subject: "Advisory Committees for Human Prescription Drugs"
section_number: "14.174"
section_subject: "Advice and recommendations in writing."
cfr_reference: "21 CFR 14.174"
title_name: "Title 21"
title_subject: "Food and Drugs"
parts_covered: "Parts 1 to 99"
revised_date: "Revised as of April 1, 2019"
publication_date: "As of April 1, 2019"
contains_description: "Containing a codification of documents of general applicability and future effect"
publication_info: "Published by the Office of the Federal Register National Archives and Records Administration as a Special Edition of the Federal Register"
---
Advice and recommendations given by a committee on a specific drug or a class of drugs are ordinarily in the form of a written report. The report may consist of the approved minutes of the meeting or a separate written report. The report responds to the specific issues or questions which the Commissioner has addressed to the advisory committee, and states the basis of the advice and recommendations of the committee.